Prognostic value of test(s) for O(6)‐methylguanine–DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide

This is a protocol for a Cochrane Review (Prognosis). The objectives are as follows: Primary objective The primary objective of this review is to determine which technique (test) for assessing MGMT methylation status best predicts overall survival in people diagnosed with glioblastoma who are treate...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cochrane Database Syst Rev
Päätekijät: McAleenan, Alexandra, Howell, Amy, Kernohan, Ashleigh, Faulkner, Claire L, Dawson, Sarah, Wragg, Christopher, Jefferies, Sarah, Brandner, Sebastian, Vale, Luke, Higgins, Julian P T, Kurian, Kathreena M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Ltd 2019
Aiheet:
Medicine General & Introductory Medical Sciences
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489695/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013316
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia